These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2447409)

  • 1. Effects of long-term therapy with oral piroximone on resting hemodynamics, peak aerobic capacity, and the anaerobic threshold in patients with heart failure.
    Nemanich JW; Shurman AJ; Rossen JD; Kremser C; Davis F; Rajfer SI
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):580-8. PubMed ID: 2447409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroximone (MDL 19,205) in the treatment of unstable and stable chronic cardiac failure.
    Weber KT; Janicki JS; Jain MC
    Am Heart J; 1987 Oct; 114(4 Pt 1):805-13. PubMed ID: 3310566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
    Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with piroximone in patients with chronic heart failure.
    Baumann G; Ningel K; Cremer G
    Int J Cardiol; 1990 Nov; 29(2):195-204. PubMed ID: 2269538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of a constant intravenous infusion of piroximone in patients with severe congestive heart failure.
    Miller WE; Kennedy GT; Ruberg SJ; O'Rourke RA; Crawford MH
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):72-7. PubMed ID: 2459538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects and concentration-effect relationship of a graded infusion of piroximone in patients with severe heart failure.
    Baumann PC; Meyer BJ; Maggiorini M; Ha HR; Gallino A; Follath F
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):489-95. PubMed ID: 7681513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt CM; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1986; 8(1):82-9. PubMed ID: 2419699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive haemodynamic effects of piroximone and prostacyclin in severe chronic heart failure.
    Albo C; Saal JP; Lellouche D; Habbal R; Benvenuti C; Deleuze P; Loisance D; Castaigne A; Dubois-Randé JL
    Eur Heart J; 1994 Apr; 15(4):528-33. PubMed ID: 8070481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure.
    Baumann G; Ningel K; Vieweg J; Joder-Ohlenbusch AM; Cremer G
    Eur Heart J; 1991 Apr; 12(4):533-40. PubMed ID: 2065688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of piroximone on the right ventricular function in severe heart failure patients.
    Saal JP; Habbal R; Estagnasie P; Lellouche D; Castaigne A; Dubois-Randé JL
    Intensive Care Med; 1994 May; 20(5):341-7. PubMed ID: 7930028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
    Rubin SA; Tabak L
    J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
    Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
    Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.
    Shah PK; Amin DK; Hulse S; Shellock F; Swan HJ
    Circulation; 1985 Feb; 71(2):326-31. PubMed ID: 3155500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of oral enoximone on hemodynamics, exercise capacity, anaerobic threshold, and arrhythmias in congestive heart failure.
    Klauss V; Zwehl W; Mudra H; Huber R; Schmidt R; Scheininger M; Vogler A; Tschaidse O; Dieterich HA; Theisen K
    Klin Wochenschr; 1991 Jul; 69(10):430-5. PubMed ID: 1719270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.